Navigation Links
Prime Therapeutics Introduces Efficiency Program to Help Employers Understand How to Most Effectively Spend Pharmacy Dollars
Date:2/26/2008

ST. PAUL, Minn., Feb. 26 /PRNewswire/ -- Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today the release of its Efficiency Program. The Efficiency Program provides a targeted approach to value-based pharmacy management and helps employers understand how to spend their limited health care dollars in ways that are most beneficial to the health of their employees. Prime will be presenting this new program at the Pharmacy Benefit Management Institute (PBMI) 2008 Drug Benefit Conference on February 28, 2008.

Prime's Efficiency Program was developed as a tool to help plan sponsors control health care costs while improving the health of their members. The program focuses on core therapeutic categories where evidence-based medicine demonstrates a proven positive health outcome. For each core therapeutic category, Prime uses predictive modeling logic and medical claims information to identify members at high risk for an adverse health event within a population. Pharmacy claims are then used to determine which members have been prescribed a drug therapy and which members have not. Prime's Efficiency Program combines both pieces of information to provide a metric that plan sponsors can use to gauge how efficiently they are spending their pharmacy benefit dollars.

Patrick Gleason, PharmD, Prime's Director of Clinical Outcome Assessment, indicates, "This approach focuses on overall health care including both medical and pharmacy care. This program will help plan sponsors answer the question: are we spending our pharmacy dollars effectively and where do we need to make improvements?"

Gleason will be presenting the Efficiency Program and will provide tangible examples of the value of integrating medical and pharmacy claims to improve pharmacy benefit performance at the 2008 PBMI Drug Benefit Conference in Phoenix, Arizona, on February 28, 2008.

Using the information provided through Prime's Efficiency Program, clients may choose to implement clinical programs or value-based benefit designs, or a combination of the two. Prime offers clinical programs that implement different member interventions based on whether members are at high risk for an adverse health outcome. Value-based benefit designs provide plan sponsors with the opportunity to remove cost barriers for impacted members. This type of design often includes offering generic drugs in a particular therapeutic category at a lower cost.

As part of its commitment to supporting clients in the development of innovative pharmacy benefits, Prime was the first pharmacy benefit manager to join the Center for Health Value Innovation, a non-profit organization that collaborates with leading organizations to develop and promote value-based health strategies with the end goal of improving the health of employees.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and thirdparty administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 10 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Prime Your Immune System During the Peak of Cold Season and Beyond
2. PrimeWest Health Chooses Healthations AboveHealth as Next Generation Provider Portal
3. Prime Therapeutics Becomes First PBM to Join the Center for Health Value Innovation
4. Health Capital Group Warns of Fallout to Hospitals From the Subprime Mortgage Crisis and Urges Hospitals to Immediately Reassess Existing Debt Structures and Capital Financing Plans
5. MDS Issues MDS US GAAP Primer
6. Fetal Alcohol Exposure May Prime Offspring for Alcoholism
7. Safety Concerns Prompt Prime to Remove Avandia(R) from Formulary
8. Announcing Prime Vendor Contract with LIHPA
9. Activist Groups Plea to Indian Prime Minister: Rollout Second-Line AIDS Treatment!
10. Prime Healthcare Services Acquires Centinela Hospital Medical Center
11. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... ... Media, the industry leader in digital marketing for medical practices, has been recognized as one ... the Inc. 5000 for the second time in two years. Shawn Miele, Chief Executive Officer ... for the second year in a row. It’s extremely difficult to make this list once. ...
(Date:8/17/2017)... Yorba Linda, Ca (PRWEB) , ... August 17, 2017 , ... ... by the FDA to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. ... their 21 CFR Part 11 ruling. , Presented as part of the ...
(Date:8/16/2017)... Kalamazoo, Michigan (PRWEB) , ... August 16, 2017 , ... ... Applications are now being accepted. , Students who successfully complete the seven-week long ... a Certified Nurse Assistant (CNA). The average starting salary for a CNA in Kalamazoo ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... Greenfield Advisors ... companies in the U.S. for the second year in a row. The Inc. 5000 ... past three years. , “To be on the list once is a great accomplishment, ...
(Date:8/16/2017)... , ... August 16, 2017 , ... Any Lab ... 5000. The company ranked #4429 on the newly released, 36th annual Inc. 5000 ... a unique look at the most successful companies within the American economy’s most dynamic ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO ... as president, effective Aug. 7, 2017. ... pursue other interests and will serve as president emeritus during ... served us in multiple leadership roles since he joined Diplomat ... and has provided decisive, strategic leadership which continues to benefit ...
(Date:8/4/2017)... CINCINNATI , Aug. 3, 2017  Agragen, ... science company active in the biopharmaceutical, nutraceutical, and ... its development of its lead drug candidates, AGR131.  ... a proinflammatory cytokine from the blood of patients ... psoriasis, and inflammatory bowel disease. ...
(Date:8/2/2017)... 2017  Life Flight Network and PeaceHealth Oregon Network announced ... care and operational efficiency for patients at hospitals in ... Cottage Grove , and Florence, Oregon ... Life Flight Network work collaboratively to move patients who require ... a time sensitive emergency exists. ...
Breaking Medicine Technology: